Noriko Nakamura Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

NCTR

Last publication 2026 Last refreshed 2026-05-16

faculty

29 h-index 239 pubs 3,498 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Noriko Nakamura's research focuses on pharmacological effects and toxicity studies, particularly in the context of cardiovascular function and risk factors. She has investigated the home blood pressure-lowering effects of esaxerenone compared to trichlormethiazide for uncontrolled hypertension, conducting predefined subanalyses based on basal medication and age subgroups. Nakamura has also examined the real-life safety and effectiveness of omalizumab in pediatric patients with severe allergic asthma and in patients with chronic spontaneous urticaria through post-marketing surveillance studies.

Her work extends to evaluating physiological models for drug transfer studies, specifically a human placental barrier model. Additionally, her research has explored the development of dual-modal probes for tumor imaging and the neutralizing capacity of patient-derived monoclonal antibodies against viral infections like HCV. Nakamura leads a research group and has a significant publication record, with 233 total publications and 3,462 citations, contributing to her h-index of 29. She is recognized as a highly cited researcher. Key collaborators include Daniel T. Sloper, Matthew Bryant, Mani Chidambaram, and Elysia A. Masters, all affiliated with the National Center for Toxicological Research.

Metrics

h-index: 29
Publications: 239
Citations: 3,498

Selected Publications

Alteration of Cytokine/Chemokine Transcript Levels in the Placenta of Humanized Mouse Models Treated Prenatally With Dexamethasone (2025)

DOI OpenAlex
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model (2024)

2 citations DOI OpenAlex
Evaluation of a microphysiological human placental barrier model for studying placental drug transfer (2023)

4 citations DOI OpenAlex
Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers (2022)

3 citations DOI OpenAlex
In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats (2022)

4 citations DOI OpenAlex
Altered expression of genes identified in rats with prostatic chronic inflammation in a prostate spheroid model treated by estradiol/testosterone (2021)

2 citations DOI OpenAlex
Identification of Altered Proteins in the Plasma of Rats With Chronic Prostatic Inflammation Induced by Estradiol Benzoate and Sex Hormones (2021)

3 citations DOI OpenAlex